In collaboration with Acurian – which provides patient enrollment and retention solutions – Synexus yesterday introduced a solution for enrolling patients in clinical studies for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).

https://www.outsourcing-pharma.com/Article/2018/04/24/Acurian-Synexus-tap-database-of-100m-for-NASH-patient-enrollment-solution?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyright